Connecticut 2025 Regular Session

Connecticut House Bill HB05714 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11
22
33 LCO No. 2320 1 of 1
44
55 General Assembly Proposed Bill No. 5714
66 January Session, 2025
77 LCO No. 2320
88
99
1010 Referred to Committee on PUBLIC HEALTH
1111
1212
1313 Introduced by:
1414 REP. ANDERSON, 62nd Dist.
1515
1616
1717
1818 AN ACT REQUIRING THE PROVISION OF WRITTEN INFORMATION
1919 BY PHARMACISTS CONCERNING THE EFFECTS OF MIFEPRISTONE
2020 WHEN DISPENSING TO A PATIENT.
2121 Be it enacted by the Senate and House of Representatives in General
2222 Assembly convened:
2323
2424 That the general statutes be amended to require pharmacists that are 1
2525 dispensing mifepristone to a patient for the purposes of terminating a 2
2626 pregnancy to provide written information that its effects may, in some 3
2727 cases, be reversed if the patient decides to continue with the pregnancy 4
2828 and seeks reversal treatment in a timely manner. 5
2929 Statement of Purpose:
3030 To protect reproductive rights in cases where a woman decides to
3131 continue with a pregnancy.